peptide version of tirzepatide the Week: Tirzepatide, a Game Changer for Type 2 Diabetes and Obesity Management Who Needs Tirzepatide Peptide Therapy?

& Stokes, B

They will determine if semaglutideeither compounded or brandedis right for you

The Therapeutic Goods Administration's (TGA) warning covers the following glucagon-like peptide-1 (GLP-1) receptor agonists, which are used to treat type 2 diabetes and obesity: Semaglutide, sold as Ozempic, Wegovy Tirzepatide, sold as Mounjaro Dulaglutide, sold as Trulicity Liraglutide, sold as Saxenda The TGA said the products had the potential to cause an eye disorder called non-arteritic anterior ischaemic optic neuropathy (NAION)

Experts Urge Long-Term Strategies Beyond Medication Based on the findings, the authors conclude: "This evidence cautions against short term use of weight management medications, emphasizes the need for further research into cost effective strategies for long term weight control, and reinforces the importance of primary prevention." A US researcher echoed these concerns in a linked editorial, writing that "The study findings cast doubt on the notion that GLP-1 receptor agonists are a perfect cure for obesity." "People taking GLP-1 receptor agonists should be aware of the high discontinuation rate and the consequences of cessation of medications," he adds

FAQs What is glutathione and why is it important